Medifast Inc (MED)

EBITDA Growth

-93.42%

Quarterly · Period ending:

MED logo

MED EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-93.42%
MED Quarterly EBITDA YoY % (-218.18% → -93.42%)
High-resolution chart · PNG

MED ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Medifast Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
551.3877%
101.3453%
12.4843%
106.8262%
105.0442%
162.465%
136.3636%
-474.4681%
-282%
48.2609%
63.5071%
190.3846%
814.2857%
-475%
-1,155%
-218.1818%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.